|
|
||||
|
New ethics rules at NIH
Email: Ted Agres - tedagres@lycos.com News from The Scientist 2004, 5(1):20040304-03
|
||||
|
|
||||
|
Senior officials at the National Institutes of Health (NIH) must now file public financial disclosure forms revealing their incomes as well as any stock, fees, and payments from pharmaceutical and biotechnology companies that have dealings with the agency. The policy change was announced Monday (March 1) at the first meeting of NIH's Blue Ribbon Panel on Conflict of Interest Policies. Previously, NIH officials had been required to disclose this information, but the reports remained confidential.
|
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.